$XRTXF / $XRX.CN News September 20, 2019 XORTX An
Post# of 102241
XORTX Announces Positive Phase 2 Results in Type 2 Diabetic Nephropathy (T2DN)
https://finance.yahoo.com/news/xortx-announce...00981.html
See the Corporate profile:
http://www.thestreetnow.com/spotlight/xrx-cse-xrtxf-otcqb/
#BioPharma $LLY $AMGN $DECN